Catalyst Wire Dossier Catalyst Wire Dossier

Felmetatug Vedotin

SGN-B7H4V · Seagen (Pfizer)
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Felmetatug Vedotin, covering 2026-01-09 to 2026-01-09. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Felmetatug Vedotin/SGN-B7H4V in Advanced Solid Tumors [Phase 1]

See pricing